Vmbook Online ordering

Drug Manufacturers Major

Sure, here are general information and some financials about Zogenix, Inc. (ZGNX)

Zogenix, Inc. is a publicly traded company listed on the NASDAQ stock exchange under the ticker symbol ZGNX. The company is classified under the drug manufacturers - major industry.

Here are some key financials and earning for Zogenix, Inc. (ZGNX):

* Revenue (ttm): 84.67 million USD

* Gross Profit (ttm): 72.07 million USD

* Net Income (ttm): -58.53 million USD

* Earnings Per Share (eps) (ttm): -0.39 USD

* P/E Ratio (ttm): N/A

* Market Capitalization: 1.29 Billion USD

* Enterprise Value: 1.27 Billion USD

* Next reporting date: May 2023

It's important to note that the financial data above might be out of date or incomplete, and you should always check for the most recent information from reliable sources before making any investment decisions.

In addition to financial information, the company focuses on the development of therapies for rare and underserved conditions. Their pipeline includes therapeutics for migraine, Dravet syndrome, and other epilepsy disorders.

It's vital to do your own research, consult financial news, and seek the advice of a financial advisor before making any investment decisions.